Data for version 2 of L-arginine supplementation and risk factors of cardiovascular diseases in healthy men: a double-blind randomized clinical trial

Published on 2017-06-16T13:41:27Z (GMT) by
<h2>Clinical data on the effect of L-arginine supplementation on cardiovascular risk factors in healthy men</h2><h2>Data were collected from 52 healthy male sports club members (aged 18-35) at the Isfahan University Medical Sciences, Ishfan Iran. This was a double blind randomized controlled study where the intervention group were given 2000 mg L-arginine per day and the placebo group were given 2000mg maltodextrin per day over 45 days (November-December 2013). Please see associated article for more detailed methods.</h2>

Cite this collection

Pahavani, Naseh; Jafari, Mostafa; Rezaei, Masoud; Rasad, Hamid; Sadeghi, Omid; Ali Rahdar, Hossein; Hasan Entezari, Mohammad (2017): Data for version 2 of L-arginine supplementation and risk factors of cardiovascular diseases in healthy men: a double-blind randomized clinical trial. figshare.

https://doi.org/10.6084/m9.figshare.c.3804793.v1

Retrieved: 09:26, Oct 24, 2017 (GMT)